MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - ASSERTIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$251,000
-38.3%
386,698
+18.8%
0.00%
Q4 2019$407,000
-11.7%
325,493
-9.7%
0.00%
Q3 2019$461,000
-58.3%
360,583
+12.6%
0.00%
Q2 2019$1,105,000
-21.0%
320,361
+16.2%
0.00%
-100.0%
Q1 2019$1,398,000
+45.9%
275,722
+3.8%
0.00%
Q4 2018$958,000
-33.5%
265,527
+8.4%
0.00%
-100.0%
Q3 2018$1,440,000244,8590.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 120,600$416,0000.29%
Matarin Capital Management, LLC 762,489$2,631,0000.19%
DELTEC ASSET MANAGEMENT LLC 204,513$706,0000.16%
GLOBEFLEX CAPITAL L P 213,991$738,0000.15%
TSP Capital Management Group, LLC 88,750$306,0000.14%
Spark Investment Management LLC 512,500$1,768,0000.12%
OXFORD ASSET MANAGEMENT LLP 1,141,332$3,938,0000.08%
ALGERT GLOBAL LLC 66,842$231,0000.08%
CIGNA INVESTMENTS INC /NEW 188,018$645,0000.07%
Connor, Clark & Lunn Investment Management Ltd. 3,103,949$10,709,0000.07%
View complete list of ASSERTIO THERAPEUTICS INC shareholders